Table II.
Adverse events.
| Variables | Oxytocin group (n=37) | Carboprost group (n=36) | Oxytocin + carboprost group (n=44) | P-value |
|---|---|---|---|---|
| Nausea | 2 (5.4) | 6 (16.7) | 4 (9.1) | 0.274 |
| Vomiting | 2 (5.4) | 8 (22.2)a | 2 (4.5)b | 0.036c |
| Fever | 2 (5.4) | 3 (8.3) | 0 (0.0) | 0.096 |
| Diarrhea | 0 (0.0) | 1 (2.8) | 1 (2.3) | 0.758 |
| Headache | 0 (0.0) | 1 (2.8) | 0 (0.0) | 0.297 |
| Elevated blood pressure | 0 (0.0) | 4 (11.1) | 2 (4.5) | 0.113 |
Data are presented as number (percentage).
a
Indicates a significant difference between the given group and the oxytocin group.
b
Indicates a significant difference between the given group and carboprost group.
c
Indicates a significant difference among the three groups.